Bob Hariri is a surgeon, biomedical scientist and highly successful serial US entrepreneur in two technology sectors: biomedicine and aerospace. He has pioneered the use of stem cells to treat a range of life-threatening diseases and has made transformative contributions in the field of tissue engineering. His current positions include: the Chairman, Founder, and CSO of Celgene Cellular Therapeutics, Academic Neurosurgeon at Cornell, a Non-executive Director of Myos Corporation and Provista Diagnostics, an Adjunct Associate Professor of Pathology at the Mount Sinai School of Medicine, a member of the Board of Visitors of the Columbia University School of Engineering & Applied Sciences and the Science & Technology Council of the College of Physicians and Surgeons, and of the scientific advisory board for the Archon X PRIZE for Genomics.